YUQORI JAG’ OSTEONEKROZI
Keywords:
yuqori jag`, osteonekroz, osteomiyelit, COVID-19.Abstract
Hozirgi kunda butun dunyoda COVID-19 global pandemiyasi keltirib chiqargan asoratlar tibbiyotning barcha sohalarida o’rganilmoqda. Oldingi adabiyotlarda og'iz bo'shlig'idagi yaralar, toshmalar va so'lak bezlarining yallig'lanishi kabi o'zgarishlar COVID-19 belgilari yoki asoratlari sifatida aniqlangan holatlar qayd etilgan. Ushbu maqolada COVID-19 ning jiddiy asoratlari muhokama qilinadi, bu odatiy osteomielitdan sezilarli farq qiladi, bunda bemorlar uzoq muddatli, surunkali-progressiv, atrofik jarayonlarning rivojlanishini boshdan kechiradilar. Bemorlarda mahalliy surunkali yallig'lanishning bo’lishi va metabolik muammolar, mikrosirkulyatsiyaning buzilishi, qandli diabet, immunitet hamda qon ivishining buzilishi tufayli davolanishda biroz muammolar bo'ladi.
References
Prezioso C., Marcocci M.E., Palamara A.T., De Chiara G., Pietropaolo V. The “Three Italy” of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia. J. Neurovirol. 2020;26:311–323. doi: 10.1007/s13365020-00862-z.
Christensen RH, Berg RMG. Vascular Inflammation as a therapeutic target in COVID-19 “Long Haulers”: HIITing the spot? Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.643626.
Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia, and inflammation. Physiol Rep.
Halboub E, Al-Maweri SA, Alanazi RH, Qaid NM, Abdulrab S. Orofacial manifestations of COVID-19: a brief review of the published literature. Braz Oral Res. 2020;34:e124. doi: 10.1590/1807-3107bor-2020.vol34.0124.
Boymuradov S.A., Rustamova D.A., Bobamuratova D.T., Kurbanov Y.X., Karimberdiyev B.I., Yusupov S.Sh., et al. Complications of COVID-19 in the maxillo-facial region: clinical case and review of the literature. Adv Oral Maxillofac Surg. 2021;3 doi: 10.1016/j.adoms.2021.100091. ISSN 2667-1476.
Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist. 2008;13(8):911–920. doi: 10.1634/theoncologist.2008-0091. Epub 2008 Aug 11. PMID: 18695259.
7. Bisdas S, Chambron Pinho N, Smolarz A, Sader R, Vogl TJ, Mack MG. Biphosphonateinduced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin. Journal of Innovation in Education and Social Research, Volume: 2 Issue: 1 Year: 2024, ISSN: 2992-894X Radiol. 2008;63(1):71–77. doi: 10.1016/j.crad.2007.04.023. Epub 2007 Oct 22. PMID: 18068792.
Bianchi SD, Scoletta M, Cassone FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):249–258. doi 10.1016/j.tripleo.2007.01.040. Epub 2007 Jun 7. PMID: 17560140.
Cornah J, O'Hare PM. Total maxillary necrosis following severe facial injury. A case report. Br J Oral Surg. 1981;19(2):148–150. doi: 10.1016/0007-117x(81)90042-1. PMID: 6942882.
Kramer FJ, Baethge C, Swennen G, Teltzrow T, Schulze A, Berten J, et al. Intra- and perioperative complications of the LeFort I osteotomy: a prospective evaluation of 1000 patients. J Craniofac Surg. 2004;15(6):971–977. doi: 10.1097/00001665-200411000-00016. discussion 978-9.PMID: 15547385.
Auluck A. Maxillary necrosis by mucormycosis. A case report and literature review. Med Oral Patol Oral Cir Bucal. 2007;12(5):E360. PMID: 17767099.
Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumor patients–a report of a thirty-year retrospective review. Int J Oral Maxillofac Surg. 2003;32(3):289–295. doi: 10.1054/ijom.2002.0332. PMID: 12767877.
Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist. 2008;13(8):911–920. doi: 10.1634/theoncologist.2008-0091. Epub 2008 Aug 11. PMID: 18695259.
Du F, Liu B, Zhang S. COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness. J Thromb Thrombolysis. 2021;51(2):313–329. doi: 10.1007/s11239-020-02224-2. PMID: 32676883; PMCID: PMC7365308.
Lacey DC, Simmons PJ, Graves SE, Hamilton JA. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarth Cartilage. 2009;17(6):735–742. doi: 10.1016/j.joca.2008.11.011. Epub 2008 Nov 24. PMID: 19136283.
Radiol Case Rep. 2022 Sep; 17(9): 3228–3232. Published online 2022 Jul 2. doi: 10.1016/j.radcr.2022.06.009 (https://doi.org/10.1016%2Fj.radcr.2022.06.009)
